Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Oncogenic mutations in histologically normal endometrium: the new normal?
2019
Cancer statistics, 2023
2023 Standout
Untangling the ErbB signalling network
2001 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells
2008
Premature Rupture of the Fetal Membranes
1998 Standout
Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study
2022
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
EGFR and cancer prognosis
2001 Standout
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
2012
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Two-Color, Cytokeratin-Labeled DNA Flow Cytometric Analysis of 332 Breast Cancers
2001
EGFR Antagonists in Cancer Treatment
2008 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
Outcome of Pulmonary Vascular Disease in Pregnancy: A Systematic Overview From 1978 Through 1996
1998
QuPath: Open source software for digital pathology image analysis
2017 Standout
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas
2009
Ovarian cancer biomarkers for molecular biosensors and translational medicine
2010
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Novel Vertebrate Genes and Putative Regulatory Elements Identified at Kidney Disease and NR2E1/fierce Loci
2002 StandoutNobel
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue
2009
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
2012
Dichotomizing continuous predictors in multiple regression: a bad idea
2005 Standout
Interstitial Collagen Synthesis and Processing in Human Amnion: A Property of the Mesenchymal Cells1
1996
Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha,myc, jun, and metallothionein in human ovarian carcinomas classification of malignant phenotypes
1993
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Uterine fibroids
2001 Standout
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Neutrophils, from Marrow to Microbes
2010 Standout
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
1999
Assessing the Performance of Prediction Models
2009 Standout
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
2015 Standout
CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract
1997
Biliary glycoprotein (BGP) expression on T cells and on a natural-killer-cell sub-population
1996
Confidence intervals for the effect of a prognostic factor after selection of an ‘optimal’ cutpoint
2004
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Fertility and pregnancy outcome after myomectomy in sterility patients
1996
Estrogen action in human ovarian cancer
1997
NK CELL RECOGNITION
2004 Standout
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Further refining 2020 ESGO /ESTRO /ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis
2022
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
How to Assess Prognostic Models for Survival Data: A Case Study in Oncology
2003
Endometriosis
2020 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Regression Modeling Strategies
2015 Standout
Strictly Proper Scoring Rules, Prediction, and Estimation
2007 Standout
Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
1997
The Role of CSF‐1 in Normal and Neoplastic Breast Physiology
1999
Works of F. Kommoss being referenced
Immunohistochemical localization of throm☐ane synthase in human intrauterine tissues
1994
Independent prognostic significance of cell cycle regulator proteins p16INK4a and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
2007
VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection
2009
Co‐expression of M‐CSF transcripts and protein, FMS (M‐CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary
1994
A polymerase‐chain‐reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)‐gene‐family members
1993
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
2018
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
2018
Geburtshilfliche Komplikationen, Frequenz und Indikationen der Kaiserschnittentbindungen bei Uterus myomatosus
1993
Primäre pulmonale Hypertonie und Schwangerschaft
1991
Iatrogenic endometriosis harbors somatic cancer-driver mutations
2018
Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
1994
Steroid receptors in ovarian carcinoma: Immunohistochemical determination may lead to new aspects
1993
Expression analysis of EGF-R and TGFa in human ovarian carcinomas.
1992
Estrogen and progesterone receptors in ovarian neoplasms: discrepant results of immunohistochemical and biochemical methods
1991
DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors.
1995